Short answer
The answer in plain English
Some Medicare Part D premiums could rise in 2027 because a temporary federal demonstration that reduced premiums for participating stand-alone drug plans ends after 2026. The change does not determine every plan’s price: actual premiums depend on each insurer’s bid, region, benefits, and subsidies, and CMS will publish finalized plan information before open enrollment.
Why it matters
What to understand
The temporary Premium Stabilization Demonstration softened price changes while insurers adapted to the redesigned Part D benefit. Its end removes one layer of support for stand-alone prescription drug plans, so some members may see a higher monthly premium. That is separate from the statutory cap on growth in the national base beneficiary premium and from the annual out-of-pocket limit for covered drugs. Compare total annual cost, not premium alone.
Two different premium protections are easy to confuse
The change concerns the Part D Premium Stabilization Demonstration, a temporary program for participating stand-alone prescription drug plans. It is not the same as the Inflation Reduction Act rule that limits annual growth in the national base beneficiary premium through 2029.
For 2026, the demonstration reduced the base premium used by participating plans and limited how much their total premium could rise. CMS had already reduced that extra support from its 2025 level. Ending it after 2026 removes the demonstration discount and increase limit.
The separate statutory formula remains. CMS’s 2027 Advance Notice said the 2027 national base beneficiary premium could not exceed $41.33, six percent above the 2026 figure. That national calculation is an input—not a promise that every member’s plan premium rises by no more than six percent.
Why the demonstration existed
Part D’s benefit design changed substantially. Plan sponsors took on more liability for expensive prescriptions, the coverage gap disappeared, and members stopped paying cost sharing after reaching the annual out-of-pocket threshold for covered drugs. The temporary demonstration was intended to smooth premium changes while insurers gained experience pricing that new structure.
In 2025 it provided a larger uniform reduction and a tighter year-over-year increase limit. CMS scaled both back for 2026, saying the market should move toward regular conditions. The decision to conclude the program finishes that transition.
What is known—and what is not
The direction of pressure is clear: remove a subsidy and participating plans lose a payment that had lowered premiums. That makes increases possible and, for some plans, likely.
The exact consumer result is not known from the policy change alone. Insurers submit different bids; stand-alone Part D and Medicare Advantage drug coverage are structured differently; plans can change formularies and pharmacy networks; and income-based assistance alters what some members pay. Final premiums and available plans are published closer to open enrollment.
This is why a headline estimate should not be entered into a household budget as if it were a bill. Check the actual plan serving your ZIP code and prescriptions.
Premium is only one cost
A low monthly premium can be expensive if a needed drug is excluded, placed on a costly tier, or available only through an inconvenient pharmacy. A higher-premium plan can sometimes reduce total spending through better coverage.
Compare at least these pieces:
- twelve months of premiums;
- the deductible and whether it applies to your medicines;
- the formulary tier and restrictions for every regular prescription;
- preferred and in-network pharmacies;
- expected copays or coinsurance;
- the annual out-of-pocket limit for covered Part D drugs.
The out-of-pocket threshold and the premium are separate. Reaching the threshold can stop further cost sharing for covered drugs, but monthly premiums do not count toward it and continue to be due.
How to prepare for open enrollment
Keep an updated list of drug names, doses, and refill frequency. When official 2027 data appears, enter that list into Medicare’s Plan Finder and compare estimated total yearly cost, not just the first premium shown. Check whether the pharmacy you actually use is preferred and whether prior authorization or step therapy applies.
People who qualify for the Low-Income Subsidy, also called Extra Help, may face a different calculation and should verify eligibility. A State Health Insurance Assistance Program counselor can provide free, local comparison help.
Automatic renewal is convenient, but it is not a cost analysis. For 2027, the safest response to uncertainty is a fresh comparison using finalized plan data.